M
M. A. Pfaller
Researcher at University of Iowa
Publications - 233
Citations - 24947
M. A. Pfaller is an academic researcher from University of Iowa. The author has contributed to research in topics: Broth microdilution & Fluconazole. The author has an hindex of 90, co-authored 233 publications receiving 24005 citations. Previous affiliations of M. A. Pfaller include Roy J. and Lucille A. Carver College of Medicine & University of Toronto.
Papers
More filters
Journal ArticleDOI
Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
Daniel J. Diekema,M. A. Pfaller,F. J. Schmitz,J. Smayevsky,Jan M. Bell,R N Jones,Mondell L. Beach +6 more
TL;DR: Given the increasing multidrug resistance among staphylococci and the possible emergence of vancomycin-resistant strains, global strategies are needed to control emergence and spread of multiply resistant staphlyococci.
Journal ArticleDOI
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Dionissios Neofytos,D. Horn,Elias Anaissie,William J. Steinbach,Ali J. Olyaei,Jay A. Fishman,M. A. Pfaller,C. Chang,K. Webster,Kieren A. Marr,Kieren A. Marr +10 more
TL;DR: IA remains the most commonly identified IFI among HSCT recipients, but rates of survival in persons with IA appear to have improved, compared with previously reported data.
Journal ArticleDOI
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus
M. A. Pfaller,Daniel J. Diekema +1 more
TL;DR: The frequency of invasive mycoses due to opportunistic fungal pathogens has increased significantly over the past two decades ([35][1], [74][2], [83][3], [88][4], [89][5], [101][6], [106][7]).
Journal ArticleDOI
Risk factors for candidemia in neonatal intensive care unit patients
Lisa Saiman,E Ludington,M. A. Pfaller,S Rangel-Frausto,R T Wiblin,Jeffrey D. Dawson,Henry M. Blumberg,Jan E. Patterson,Michael G. Rinaldi,Joanne Edwards,Richard P. Wenzel,William R. Jarvis +11 more
TL;DR: The incidence of candidemia might be decreased by the judicious use of treatments identified as risk factors and avoiding H2 blockers, according to a prospective cohort study performed in six NICU patients from 1993 to 1995.
Journal ArticleDOI
National Epidemiology of Mycoses Survey (NEMIS): Variations in Rates of Bloodstream Infections Due to Candida Species in Seven Surgical Intensive Care Units and Six Neonatal Intensive Care Units
M. S. Rangel-Frausto,T. Wiblin,Henry M. Blumberg,Lisa Saiman,Jan E. Patterson,M. Rinaldi,M. A. Pfaller,John E. Edwards,William R. Jarvis,Jeffrey D. Dawson,Richard P. Wenzel +10 more
TL;DR: Of the patients, 30%-50% developed incidental stool colonization, 23% of S ICU patients developed incidental urine colonization, and one-third of SICU health care workers' hands were positive for Candida species.